File image of a nurse holding vials of AstraZeneca vaccine towards COVID-19
| Photograph Credit score: AP
AstraZeneca mentioned on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine attributable to a “surplus of obtainable up to date vaccines” for the reason that pandemic.
(For prime well being information of the day, subscribe to our e-newsletter Well being Issues)
The corporate additionally mentioned it might proceed to withdraw the vaccine Vaxzevria’s advertising and marketing authorisations inside Europe.
“As a number of, variant COVID-19 vaccines have since been developed there’s a surplus of obtainable up to date vaccines,” the corporate mentioned, including that this had led to a decline in demand for Vaxzevria, which is not being manufactured or equipped.
In line with media studies, the Anglo-Swedish drugmaker has beforehand admitted in courtroom paperwork that the vaccine causes side-effects resembling blood clots and low blood platelet counts.
The agency’s software to withdraw the vaccine was made on March 5 and got here into impact on Could 7, in line with the Telegraph, which first reported the event.
London-listed AstraZeneca started transferring into respiratory syncytial virus vaccines and weight problems medication by means of a number of offers final 12 months after a slowdown in progress as COVID-19 medication gross sales declined.
